The Interpretation Of the ankyrin

Proportional hazards models were also used to model mortality and hospitalization as a function of the number of missed (or shortened) treatments in the prior month. The software SAS version 9��2 (SAS Institute, Cary, NC, USA) was utilized for all analyses. GSK-3 inhibitor review The study was approved both by the Morehouse School of Medicine Institutional Review Board and the DCI internal Review Board. Results The baseline demographic variables of the patients are shown in Table ?Table1.1. The median age of the patients was 63 years during the study period and they were followed for an average of 12.4 months per patient. The median number of years on dialysis was 1.8 years. There were 2 297 227 HD treatments of which 55 928 (2.4%) were missed treatments and 354 510 (15.4%) were shortened treatments. ankyrin DCI clinics with high rates of missed treatments showed that patients who missed a treatment were also more likely to have high rates of shortened treatments, r = 0.53, P Quisinostat treatments is shown in Figure ?Figure2,2, while the effect of age on shortened treatments is shown in Table ?Table4.4. Patients aged